$NRSN

$2.19▲ +10.1% YTD

9 SEC 13D/G filings tracked · Last updated Nov 2, 2026

Filing History

News

NRSN ▲ +10.1% - NeuroSense Therapeutics Ltd.

CP $2.19▲ +10.1%Nov 2, 2026 · ThinkSabio Blog

$NRSN NRSN NRSNW - NeuroSense to Strengthen PrimeC Canadian ALS Submission With New NfL Data…

News

NRSN ▼ -6.2% - NeuroSense Therapeutics Ltd.

CP $2.12▲ -6.2%Oct 29, 2026 · ThinkSabio Blog

$NRSN NRSN - NeuroSense to Present Integrated Clinical and Biomarker Evidence Shaping PrimeC's Phase 3 Development at NEALS 2026…

News

NRSN ▼ -2.4% - NeuroSense Therapeutics Ltd.

CP $2.40▲ -2.4%Oct 26, 2026 · ThinkSabio Blog

$NRSN - Form 6K - signed a strategic collaboration agreement with an advisor to advance a revenue-generating supply of PrimeC, its lead therapeutic ca…

News

NRSN ▼ -8.1% - NeuroSense Therapeutics Ltd.

CP $2.82▲ -8.1%Oct 19, 2026 · ThinkSabio Blog

$NRSN NRSN NRSNW - NeuroSense Files U.S. Patent Application for Traumatic Brain Injury…

News

NRSN ▲ +3.9% - NeuroSense Therapeutics Ltd.

CP $3.48▲ +3.9%Oct 13, 2026 · ThinkSabio Blog

$NRSN NRSNW NRSN NRSNW - NeuroSense Secures Nasdaq Hearing Date as PrimeC Approaches Key Regulatory and Funding Milestones…

News

NRSN ▼ -19.0% - NeuroSense Therapeutics Ltd.

CP $5.63▲ -19.0%Sep 28, 2026 · ThinkSabio Blog

$NRSN NRSN - NeuroSense to Participate in the 5th Annual ROTH Healthcare Opportunities Conference…

News

NRSN ▼ -2.3% - NeuroSense Therapeutics Ltd.

CP $6.95▲ -2.3%Sep 25, 2026 · ThinkSabio Blog

$NRSN NRSNW - NeuroSense Provides Business Update and Progress for the First Half of 2026…

News

NRSN ▼ -7.5% - NeuroSense Therapeutics Ltd.

CP $0.37▲ -7.5%Sep 10, 2026 · ThinkSabio Blog

$NRSN NRSN NRSNW - NeuroSense to Present at H.C. Wainwright 28th Annual Global Investment Conference…

News

NRSN ▲ +9.5% - NeuroSense Therapeutics Ltd.

CP $0.46▲ +9.5%Aug 31, 2026 · ThinkSabio Blog

$NRSN NRSN - NeuroSense Unveils Accelerated, Capital-Efficient Strategy to Advance PrimeC Toward Potential Approval in ALS…